BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6979551)

  • 1. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.
    Lee S; Morimoto S; Onishi T; Tsuji M; Okada Y; Seino Y; Ishida M; Yamaoka K; Takai S; Miyauchi A; Kumahara Y
    J Clin Endocrinol Metab; 1982 Aug; 55(2):361-3. PubMed ID: 6979551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum calcium regulating hormones in the perinatal period.
    Seino Y; Ishida M; Yamaoka K; Ishii T; Hiejima T; Ikehara C; Tanaka Y; Matsuda S; Shimotsuji T; Yabuuchi H; Morimoto S; Onishi T
    Calcif Tissue Int; 1982 Mar; 34(2):131-5. PubMed ID: 6805918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism.
    Braun JJ; Juttmann JR; Visser TJ; Birkenhäger JC
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):21-8. PubMed ID: 6981468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D levels and trabecular bone remodelling before and after surgery for medullary thyroid carcinoma.
    Emmertsen K; Melsen F; Mosekilde L; Lund B; Lund B; Sørensen OH; Charles P; Møller J
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):346-9. PubMed ID: 6611007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
    Christiansen C; Christensen MS; McNair P; Nielsen B; Madsbad S
    Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
    Findling JW; Adams ND; Lemann J; Gray RW; Thomas CJ; Tyrrell JB
    J Clin Endocrinol Metab; 1982 May; 54(5):1039-44. PubMed ID: 6977549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
    Unakami H
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating vitamin D metabolite levels in hypophosphatasia.
    Whyte MP; Seino Y
    J Clin Endocrinol Metab; 1982 Jul; 55(1):178-80. PubMed ID: 6978889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
    Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
    J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxy vitamin D.
    Fuss M; Cogan E; Gillet C; Karmali R; Geurts J; Bergans A; Brauman H; Bouillon R; Corvilain J
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):807-15. PubMed ID: 3874724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.
    Stanbury SW
    J R Coll Physicians Lond; 1981 Oct; 15(4):205-9, 212-7. PubMed ID: 6976436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
    Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
    J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of parathyroid hormone on vitamin D metabolism in patients with the bone loss of aging.
    Sørensen OH; Lumholtz B; Lund B; Lund B; Hjelmstrand IL; Mosekilde L; Melsen F; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1258-61. PubMed ID: 6978888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects.
    Clemens TL; Zhou XY; Myles M; Endres D; Lindsay R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):656-60. PubMed ID: 3488327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum 24,25-dihydroxyvitamin D concentration during long-term anticonvulsant therapy in adult epileptics.
    Zerwekh JE; Homan R; Tindall R; Pak CY
    Ann Neurol; 1982 Aug; 12(2):184-6. PubMed ID: 6982022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis.
    Haug CJ; Aukrust P; Haug E; Mørkrid L; Müller F; Frøland SS
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3832-8. PubMed ID: 9814454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.